Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
Study NCT ID:
NCT04150666
Status:
WITHDRAWN
Last Update Posted:
2020-07-15
First Post:
2019-11-01
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP)
Sponsor:
Qifu Li
Organization:
Study Overview
Official Title:
The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP)
Status:
WITHDRAWN
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No subjects are willing to participating.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate whether increasing water intake has renal protective effect on PA patients after surgical treatment.
Detailed Description:
This is a single-center randomized controlled trial study to verify the effect of drinking water on renal function after PA surgery treatment and to follow up the clinical outcomes. We will take short-term follow-up on whether increasing water intake can improve eGFR decline in the early stage of PA patients after surgical treatment and further long-term follow-up to investigate whether increasing drinking water has long-term memory effect to slow down renal function deterioration and improve clinical outcomes. This study will be completed in 1 year.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: